Hepatitis C is a worldwide issue with an estimated three million infected people in the United States alone. Treatment for hepatitis C is difficult, with sometimes severe side effects, and medications are expensive, limiting treatment to those who can afford it. However, recent advances in clinical trials and changes by drug manufacturers could change the way hepatitis C is treated in the near future.
Read more of this interesting overview at http://www.inquisitr.com/1886276/hope-in-hepatitis-c-pandemic/#HTpRj4rVVYAZTyp3.99
No comments:
Post a Comment